{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:53:51Z","timestamp":1773327231557,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Ocular sarcoidosis most commonly presents with symptoms and is first diagnosed before systemic sarcoidosis in at least half of the patients with sarcoidosis. Prevalence of ocular involvement in sarcoidosis varies between 2\u201380% depending on the study setting, included ocular diseases, and studied population. In many studies, ocular involvement in sarcoidosis has been overestimated mainly because study populations have been collected from eye clinics and because the study criteria have included ocular findings or symptoms that do not require treatment or monitoring. In a screening setting, asymptomatic ocular sarcoidosis has been detected in only 2\u20135%. 0\u20131% of the screened sarcoidosis patients have required treatment. For these reasons, ocular screening in sarcoidosis seems generally of little value. Patients with sarcoidosis who present with ocular symptoms should be screened for ocular sarcoidosis in a timely manner because they are at high risk of ocular disease.<\/jats:p>","DOI":"10.3389\/fmed.2024.1348435","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T12:46:50Z","timestamp":1708346810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Ocular sarcoidosis, to screen or not to screen?"],"prefix":"10.3389","volume":"11","author":[{"given":"Sanna","family":"Leinonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"15749","DOI":"10.1111\/aos.15749","article-title":"Low utility of ocular screening in sarcoidosis in Finland","author":"Joukainen","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ophtha.2015.01.003","article-title":"Sarcoidosis in the National Veteran Population","volume":"122","author":"Birnbaum","year":"2015","journal-title":"Ophthalmology"},{"key":"ref6","first-page":"26","article-title":"Management of ocular sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"ref10","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref11","first-page":"2172","article-title":"Should patients with sarcoidosis be screened for asymptomatic ocular inflammation?","volume":"58","author":"Sunshine","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2021.1976216","article-title":"The role of screening for asymptomatic ocular inflammation in sarcoidosis","author":"Lee","year":"2022","journal-title":"Ocul. Immunol. Inflamm"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1080\/09273948.2021.1976216","article-title":"The role of screening for asymptomatic ocular inflammation in sarcoidosis","volume":"30","author":"Lee","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198805984.001.0001","volume-title":"Screening: Evidence and practice","author":"Raffle","year":"2019"},{"key":"ref15","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"ref16","first-page":"201","article-title":"Ocular manifestations in sarcoidosis","volume":"101","author":"Dr\u00f3becka","year":"1999","journal-title":"Klin Ocz"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.48.9.461","article-title":"OCULAR SARCOIDOSIS","volume":"48","author":"James","year":"1964","journal-title":"Br J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09273948.2017.1386791","article-title":"Clinical characteristics of ocular sarcoidosis: a population-based study 1976\u20132013","volume":"27","author":"Ungprasert","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0002-9394(86)90001-2","article-title":"Ocular involvement in chronic sarcoidosis","volume":"102","author":"Jabs","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/pgmj.46.538.501","article-title":"Ocular sarcoidosis","volume":"46","author":"Jackson","year":"1970","journal-title":"Postgrad Med J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3346\/jkms.2009.24.3.413","article-title":"Ocular sarcoidosis in a Korean population","volume":"24","author":"Lee","year":"2009","journal-title":"J Korean Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1600-0420.2006.00791.x","article-title":"Pattern of ocular manifestations in patients with sarcoidosis in developing countries","volume":"85","author":"Khanna","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/09273941003637502","article-title":"Ocular sarcoidosis in southern Taiwan","volume":"18","author":"Sheu","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/09273940802596526","article-title":"Ocular involvement in sarcoidosis","volume":"17","author":"Atmaca","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12348-011-0029-7","article-title":"Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis","volume":"1","author":"Pefkianaki","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10384-022-00927-y","article-title":"Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation","volume":"66","author":"Suzuki","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/eye.1999.221","article-title":"The ocular and systemic prognosis of patients presenting with sarcoid uveitis","volume":"13","author":"Edelsten","year":"1999","journal-title":"Eye"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/0002-9394(78)90184-8","article-title":"Sarcoidosis and its ophthalmic manifestations","volume":"86","author":"Obenauf","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King\u2019s sarcoidosis questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1348435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T12:46:57Z","timestamp":1708346817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1348435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":32,"alternative-id":["10.3389\/fmed.2024.1348435"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1348435","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"article-number":"1348435"}}